<p>StockNews.com 在周五发布的研究报告中开始覆盖 Walgreens Boots Alliance (NASDAQ:WBA - 获取免费报告) 的股票。该公司对这家药房运营商的股票设定了 “持有” 评级。</p>
<ul>
<li>Walgreens 复苏？私募股权公司正在寻求收购</li>
</ul>
<p>其他几位股票研究分析师也对 WBA 发表了看法。Truist Financial 将 Walgreens Boots Alliance 的目标价从 13.00 美元下调至 12.00 美元，并在 1 月 31 日的报告中对该公司设定了 “持有” 评级。德意志银行将 Walgreens Boots Alliance 的股票评级从 “持有” 下调至 “卖出”，并在 2 月 28 日的研究报告中将该公司的目标价从 11.00 美元下调至 9.00 美元。加拿大皇家银行将 Walgreens Boots Alliance 的目标价从 9.00 美元上调至 12.00 美元，并在 1 月 15 日的报告中给予该股票 “行业表现” 评级。Wolfe Research 在 2 月 24 日的研究报告中将 Walgreens Boots Alliance 的股票评级上调至 “持有”。最后，美国银行在 1 月 13 日的报告中将 Walgreens Boots Alliance 的目标价从 7.50 美元上调至 8.50 美元，并给予该股票 “表现不佳” 评级。四位股票研究分析师对该股票给予了 “卖出” 评级，七位给予了 “持有” 评级，二位给予了 “买入” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 10.59 美元。</p>
<p><strong>获取我们关于 Walgreens Boots Alliance 的最新报告</strong></p>
<h2>Walgreens Boots Alliance 价格表现</h2>
<ul>
<li>MarketBeat 周回顾 – 03/10 - 03/14</li>
</ul>
<p>WBA 周五开盘价为 10.69 美元。该公司的 50 日移动平均价格为 10.73 美元，200 日移动平均价格为 10.05 美元。该公司的市值为 92.4 亿美元，市盈率为 -1.04，市盈增长比率为 1.31，贝塔值为 0.67。该公司的债务与股本比率为 0.68，流动比率为 0.64，速动比率为 0.30。Walgreens Boots Alliance 的一年低点为 8.08 美元，一年高点为 18.83 美元。</p>
<p>Walgreens Boots Alliance (NASDAQ:WBA - 获取免费报告) 最近在 4 月 8 日发布了季度财报。该药房运营商报告季度每股收益为 0.63 美元，超出分析师共识预期的 0.53 美元，超出幅度为 0.10 美元。Walgreens Boots Alliance 的股本回报率为 17.61%，净利润率为 -5.87%。该公司本季度的收入为 385.9 亿美元，而分析师预期为 379.0 亿美元。去年同期，该公司每股收益为 1.20 美元。Walgreens Boots Alliance 本季度的收入较去年同期增长了 4.1%。整体来看，分析师预计 Walgreens Boots Alliance 在当前财政年度的每股收益为 1.6 美元。</p>
<h2>机构资金流入和流出</h2>
<ul>
<li>Walgreens Boots Alliance：不要轻易放弃这个资产冠军</li>
</ul>
<p>一些机构投资者和对冲基金最近调整了对该股票的持有。Sentry Investment Management LLC 在第一季度购买了 Walgreens Boots Alliance 的新头寸，价值约 27,000 美元。First Financial Corp IN 在第四季度将其在 Walgreens Boots Alliance 的持有量增加了 49.2%。First Financial Corp IN 目前拥有 2,685 股该药房运营商的股票，价值 25,000 美元，此前在上个季度增持了 885 股。Golden State Wealth Management LLC 在第四季度购买了 Walgreens Boots Alliance 的新头寸，价值约 26,000 美元。Riverview Trust Co 在第四季度将其在 Walgreens Boots Alliance 的持股增加了 123.8%。Riverview Trust Co 目前拥有 2,874 股该药房运营商的股票，价值 27,000 美元，此前在上个季度增持了 1,590 股。最后，Colonial Trust Co SC 在第四季度将其在 Walgreens Boots Alliance 的持有量增加了 79.5%。Colonial Trust Co SC 目前拥有 2,928 股该药房运营商的股票，价值 27,000 美元，此前在此期间增持了 1,297 股。58.59% 的股票由机构投资者持有。</p>
<h2>关于 Walgreens Boots Alliance</h2>
<p>(获取免费报告)</p>
<p>Walgreens Boots Alliance, Inc 在美国、英国、德国及国际上运营，作为一家医疗、药房和零售公司。它通过三个部门运营：美国零售药房、国际和美国医疗。美国零售药房部门从事零售药店、健康和保健服务、专业和家庭配送药房服务的运营，提供健康和保健、美容、个人护理和消费品以及一般商品。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Walgreens Boots Alliance</li>
<li>现在购买的 3 只沃伦·巴菲特股票</li>
<li>Joby Aviation：运营势头与市场情绪的对比</li>
<li>技术指标如何帮助你找到被低估的股票</li>
<li>博通的强劲表现显示出关税下降中的韧性</li>
<li>找到并盈利交易 52 周低点的股票</li>
<li>Carvana：能否逆转强劲的市场逆风？</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 Walgreens Boots Alliance 吗？</h2>
<p>在你考虑 Walgreens Boots Alliance 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃尔格林联合博姿并不在名单上。</p>
<p>虽然沃尔格林联合博姿目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

沃尔格林联合博姿

<p>StockNews.com 已对沃尔格林联合博姿（NASDAQ:WBA）启动了覆盖，给予 “持有” 评级。分析师们的意见不一，Truist Financial 将其目标价从 13.00 美元下调至 12.00 美元，而德意志银行则将评级从 “持有” 下调至 “卖出”，目标价为 9.00 美元。该股票的平均评级为 “持有”，目标价为 10.59 美元。沃尔格林报告的季度每股收益为 0.63 美元，超出预期，收入为 385.9 亿美元，同比增长 4.1%。机构投资者持有该股票的 58.59%</p>

<p>StockNews.com began coverage on shares of Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) in a research note issued on Friday. The firm set a &#34;hold&#34; rating on the pharmacy operator's stock.</p>
<div class="lb-trans"><p>StockNews.com 在周五发布的研究报告中开始覆盖 Walgreens Boots Alliance (NASDAQ:WBA - 获取免费报告) 的股票。该公司对这家药房运营商的股票设定了 “持有” 评级。</p>
</div><ul>
<li>Walgreens Comeback? Private Equity Circling for a Buyout</li>
</ul>
<div class="lb-trans"><ul>
<li>Walgreens 复苏？私募股权公司正在寻求收购</li>
</ul>
</div><p>Several other equities research analysts have also weighed in on WBA. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a &#34;hold&#34; rating for the company in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a &#34;hold&#34; rating to a &#34;sell&#34; rating and lowered their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Royal Bank of Canada raised their price objective on shares of Walgreens Boots Alliance from $9.00 to $12.00 and gave the stock a &#34;sector perform&#34; rating in a report on Wednesday, January 15th. Wolfe Research upgraded shares of Walgreens Boots Alliance to a &#34;hold&#34; rating in a research note on Monday, February 24th. Finally, Bank of America raised their price target on Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an &#34;underperform&#34; rating in a report on Monday, January 13th. Four equities research analysts have rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of &#34;Hold&#34; and an average price target of $10.59.</p>
<div class="lb-trans"><p>其他几位股票研究分析师也对 WBA 发表了看法。Truist Financial 将 Walgreens Boots Alliance 的目标价从 13.00 美元下调至 12.00 美元，并在 1 月 31 日的报告中对该公司设定了 “持有” 评级。德意志银行将 Walgreens Boots Alliance 的股票评级从 “持有” 下调至 “卖出”，并在 2 月 28 日的研究报告中将该公司的目标价从 11.00 美元下调至 9.00 美元。加拿大皇家银行将 Walgreens Boots Alliance 的目标价从 9.00 美元上调至 12.00 美元，并在 1 月 15 日的报告中给予该股票 “行业表现” 评级。Wolfe Research 在 2 月 24 日的研究报告中将 Walgreens Boots Alliance 的股票评级上调至 “持有”。最后，美国银行在 1 月 13 日的报告中将 Walgreens Boots Alliance 的目标价从 7.50 美元上调至 8.50 美元，并给予该股票 “表现不佳” 评级。四位股票研究分析师对该股票给予了 “卖出” 评级，七位给予了 “持有” 评级，二位给予了 “买入” 评级。根据 MarketBeat.com 的数据，该公司目前的平均评级为 “持有”，平均目标价为 10.59 美元。</p>
</div><p><strong>Get Our Latest Report on Walgreens Boots Alliance</strong></p>
<div class="lb-trans"><p><strong>获取我们关于 Walgreens Boots Alliance 的最新报告</strong></p>
</div><h2>Walgreens Boots Alliance Price Performance</h2>
<div class="lb-trans"><h2>Walgreens Boots Alliance 价格表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 03/10 - 03/14</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 03/10 - 03/14</li>
</ul>
</div><p>WBA opened at $10.69 on Friday. The firm's fifty day moving average price is $10.73 and its two-hundred day moving average price is $10.05. The company has a market capitalization of $9.24 billion, a price-to-earnings ratio of -1.04, a P/E/G ratio of 1.31 and a beta of 0.67. The company has a debt-to-equity ratio of 0.68, a current ratio of 0.64 and a quick ratio of 0.30. Walgreens Boots Alliance has a 1 year low of $8.08 and a 1 year high of $18.83.</p>
<div class="lb-trans"><p>WBA 周五开盘价为 10.69 美元。该公司的 50 日移动平均价格为 10.73 美元，200 日移动平均价格为 10.05 美元。该公司的市值为 92.4 亿美元，市盈率为 -1.04，市盈增长比率为 1.31，贝塔值为 0.67。该公司的债务与股本比率为 0.68，流动比率为 0.64，速动比率为 0.30。Walgreens Boots Alliance 的一年低点为 8.08 美元，一年高点为 18.83 美元。</p>
</div><p>Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last issued its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The business had revenue of $38.59 billion for the quarter, compared to analyst estimates of $37.90 billion. During the same period last year, the company posted $1.20 earnings per share. Walgreens Boots Alliance's quarterly revenue was up 4.1% compared to the same quarter last year. As a group, analysts anticipate that Walgreens Boots Alliance will post 1.6 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Walgreens Boots Alliance (NASDAQ:WBA - 获取免费报告) 最近在 4 月 8 日发布了季度财报。该药房运营商报告季度每股收益为 0.63 美元，超出分析师共识预期的 0.53 美元，超出幅度为 0.10 美元。Walgreens Boots Alliance 的股本回报率为 17.61%，净利润率为 -5.87%。该公司本季度的收入为 385.9 亿美元，而分析师预期为 379.0 亿美元。去年同期，该公司每股收益为 1.20 美元。Walgreens Boots Alliance 本季度的收入较去年同期增长了 4.1%。整体来看，分析师预计 Walgreens Boots Alliance 在当前财政年度的每股收益为 1.6 美元。</p>
</div><h2>Institutional Inflows and Outflows</h2>
<div class="lb-trans"><h2>机构资金流入和流出</h2>
</div><ul>
<li>Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet</li>
</ul>
<div class="lb-trans"><ul>
<li>Walgreens Boots Alliance：不要轻易放弃这个资产冠军</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of the stock. Sentry Investment Management LLC bought a new position in shares of Walgreens Boots Alliance in the first quarter worth approximately $27,000. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% in the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator's stock worth $25,000 after acquiring an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Riverview Trust Co raised its stake in shares of Walgreens Boots Alliance by 123.8% during the fourth quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator's stock valued at $27,000 after acquiring an additional 1,590 shares during the last quarter. Finally, Colonial Trust Co SC boosted its holdings in shares of Walgreens Boots Alliance by 79.5% during the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator's stock worth $27,000 after purchasing an additional 1,297 shares during the period. 58.59% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近调整了对该股票的持有。Sentry Investment Management LLC 在第一季度购买了 Walgreens Boots Alliance 的新头寸，价值约 27,000 美元。First Financial Corp IN 在第四季度将其在 Walgreens Boots Alliance 的持有量增加了 49.2%。First Financial Corp IN 目前拥有 2,685 股该药房运营商的股票，价值 25,000 美元，此前在上个季度增持了 885 股。Golden State Wealth Management LLC 在第四季度购买了 Walgreens Boots Alliance 的新头寸，价值约 26,000 美元。Riverview Trust Co 在第四季度将其在 Walgreens Boots Alliance 的持股增加了 123.8%。Riverview Trust Co 目前拥有 2,874 股该药房运营商的股票，价值 27,000 美元，此前在上个季度增持了 1,590 股。最后，Colonial Trust Co SC 在第四季度将其在 Walgreens Boots Alliance 的持有量增加了 79.5%。Colonial Trust Co SC 目前拥有 2,928 股该药房运营商的股票，价值 27,000 美元，此前在此期间增持了 1,297 股。58.59% 的股票由机构投资者持有。</p>
</div><h2>About Walgreens Boots Alliance</h2>
<div class="lb-trans"><h2>关于 Walgreens Boots Alliance</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>(获取免费报告)</p>
</div><p>Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.</p>
<div class="lb-trans"><p>Walgreens Boots Alliance, Inc 在美国、英国、德国及国际上运营，作为一家医疗、药房和零售公司。它通过三个部门运营：美国零售药房、国际和美国医疗。美国零售药房部门从事零售药店、健康和保健服务、专业和家庭配送药房服务的运营，提供健康和保健、美容、个人护理和消费品以及一般商品。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Walgreens Boots Alliance</li>
<li>3 Warren Buffett Stocks to Buy Now</li>
<li>Joby Aviation: Operational Momentum vs. Market Sentiment</li>
<li>How Technical Indicators Can Help You Find Oversold Stocks</li>
<li>Broadcom's Big Outperformance Shows Strength Amid Tariff Decline</li>
<li>Find and Profitably Trade Stocks at 52-Week Lows</li>
<li>Carvana: Can Turnaround Strength Outdrive Market Headwinds?</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Walgreens Boots Alliance</li>
<li>现在购买的 3 只沃伦·巴菲特股票</li>
<li>Joby Aviation：运营势头与市场情绪的对比</li>
<li>技术指标如何帮助你找到被低估的股票</li>
<li>博通的强劲表现显示出关税下降中的韧性</li>
<li>找到并盈利交易 52 周低点的股票</li>
<li>Carvana：能否逆转强劲的市场逆风？</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9V0JB" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=WBA"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送电子邮件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Walgreens Boots Alliance Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 Walgreens Boots Alliance 吗？</h2>
</div><p>Before you consider Walgreens Boots Alliance, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Walgreens Boots Alliance 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Walgreens Boots Alliance wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其向客户推荐的股票。MarketBeat 已经识别出五只顶级分析师正在悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而沃尔格林联合博姿并不在名单上。</p>
</div><p>While Walgreens Boots Alliance currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然沃尔格林联合博姿目前在分析师中被评为减持，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

沃尔格林联合博姿（NASDAQ:WBA）现在由 StockNews.com 的分析师进行覆盖